Utilizing Real-World Data and Algorithmic Analyses to Assess Post-Market Clinical Outcomes in Patients Switching Amongst Therapeutically Equivalent Complex Generic Drug Products and Reference Listed Drugs (U01) Clinical Trial Not Allowed
Administered by Food and Drug Administration
About this grant
Complex generic drug products represent an increasing share of the generic marketplace and may have distinct user interface differences compared to reference listed drug (RLD) products. A modernized post-market surveillance approach is needed to compare clinical outcomes between complex generic products and their corresponding RLD products to monitor for potential issues with therapeutic equivalence and to inform regulatory decision making. Real-world data (RWD) combined with machine learning (M Grant Number: FOR-FD-24-003. Expected awards: 1.
Key facts
Eligibility requirements
All of the following criteria must be met:
- Applicant organizations may submit more than one application, provided that each application is scientifically distinct. The FDA will not accept duplicate or highly overlapping applications under review at the same time per 2.3.7.4 Submission of Resubmission Application. This means that the NIH or FDA will not accept:•A new (A0) application that is submitted before issuance of the summary statemen
What the funding covers
- Award Range: $300K to $300K
- Expected Number of Awards: 1
How to apply
- 1Check eligibility: Confirm your organization type (e.g., nonprofit, state government), project alignment, and deadlines from the opportunity synopsis.
- 2Register: Create a Grants.gov account via Login.gov, complete SAM.gov and UEI registration, and authorize organization representatives (takes 2-4 weeks).
- 3Prepare application: Select "Apply" to open Workspace, download forms (e.g., SF-424), complete offline/online with validation checks, and upload supporting docs like budgets and narratives.
- 4Submit and track: Check package for errors, sign/submit via Authorized Organization Representative (AOR), and monitor status with your tracking number
- 5Applications must be submitted through grants.gov
- 6Grant Number: FOR-FD-24-003
- 7Posted: 2023-11-24
Application tips
Grant details are sourced from official public databases and reviewed weekly. Eligibility criteria, funding amounts, and deadlines may change without notice. Always confirm details on the Food and Drug Administration website before applying.
Ready to put this grant to work?
Raftlabs helps established businesses turn funding into working software, loyalty apps, and AI tools.
Talk to Raftlabs →Other grants in United States
More funding opportunities that may match your business
PRIA 5 Training Development
Any agency
PRIA 5 Training Development offered by Any agency.
PRIA 5 Training Development
Environmental Protection Agency
PRIA 5 Training Development offered by Environmental Protection Agency.
BJA FY25 John R. Justice (JRJ) Formula Grant Program
Any agency
BJA FY25 John R. Justice (JRJ) Formula Grant Program - Grant opportunity from Any agency